|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
07630 IMPACT THERAP-B
Nominal 
() | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | |
| Turnover | 38,251 | 14.022% | 33,547 |
| Cost of Sales | (1,571) | 1.029% | (1,555) |
| Gross Profit | 36,680 | 14.654% | 31,992 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | |
| Profit / (Loss) before Taxation | (295,923) | 16.161% | (254,752) | |
| Taxation | (1) | -66.667% | (3) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (295,924) | 16.160% | (254,755) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 65,877 | 37.244% | 48,000 |
| Depreciation & Amortisation | 4,474 | -32.762% | 6,654 |
| Directors' Emoluments | 63,804 | 507.484% | 10,503 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | |
| EPS (cts) | -- | -- | -- |
| DPS (cts) | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- |
| NBV per share ($) | -- | -- | -- |
| Remarks: | Real time quote last updated: 08/05/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -295,924 |
| %Change | 16.160% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |